HTG2014-Section-Header-publications

2021

Safety and efficacy of CD3-Targeting Naratuximab Emtansine plus Rituximab in Diffuse Large B-cell Lymphoma and Other Non-Hodgkin's B-cell Lymphomas - a Phase 2 Study

Levy, M. Y., et al. Safety and efficacy of CD3-Targeting Naratuximab Emtansine plus Rituximab in Diffuse Large B-cell Lymphoma and Other Non-Hodgkin's B-cell Lymphomas - a Phase 2 Study. Poster presentation presented at: 16th International Conference on Malignant Lymphoma (ICML) Lugano. June 18-22, 2021

View External Link

2016

Page last updated September 16, 2021